Marshall Wace
ONC

Marshall Wace’s BeOne Medicines Ltd ONC Stock Holding History

Marshall Wace’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7M Buy
177,987
+5,344
+3% +$1.57M 0.04% 374
2026
Q1 		$51.3M Buy
172,643
+20,347
+13% +$6.59M 0.05% 356
2025
Q4 		$46.3M Sell
152,296
-160,141
-51% -$52.4M 0.04% 358
2025
Q3 		$106M Sell
312,437
-155,153
-33% -$47.1M 0.11% 157
2025
Q2 		$113M Sell
467,590
-9,553
-2% -$2.34M 0.13% 145
2025
Q1 		$130M Buy
477,143
+445,981
+1,431% +$104M 0.16% 104
2024
Q4 		$5.76M Sell
31,162
-14,777
-32% -$3.02M 0.01% 998
2024
Q3 		$10.3M Sell
45,939
-6,048
-12% -$1.09M 0.01% 753
2024
Q2 		$7.42M Sell
51,987
-52,428
-50% -$8.08M 0.01% 852
2024
Q1 		$16.3M Buy
104,415
+36,516
+54% +$5.88M 0.02% 586
2023
Q4 		$12.2M Buy
+67,899
New +$12.3M 0.02% 630
2022
Q3 		– Sell
-2,842
Closed -$461K – 3883
2022
Q2 		$461K Sell
2,842
-26,134
-90% -$4.08M ﹤0.01% 2825
2022
Q1 		$5.46M Buy
28,976
+13,208
+84% +$2.81M 0.01% 1295
2021
Q4 		$4.27M Buy
+15,768
New +$5.32M 0.01% 1482
2021
Q1 		– Sell
-74,117
Closed -$19.2M – 2927
2020
Q4 		$19.2M Buy
+74,117
New +$20.4M 0.1% 201
2018
Q4 		– Sell
-37,061
Closed -$6.38M – 1851
2018
Q3 		$6.38M Buy
+37,061
New +$6.23M 0.05% 408
2016
Q4 		– Sell
-7,678
Closed -$237K – 1142
2016
Q3 		$237K Buy
+7,678
New +$223K ﹤0.01% 878

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's ONC Position: Q2 2026 in Review

Marshall Wace increased its BeOne Medicines Ltd (ONC) stake by 3.1% in Q2 2026, buying an estimated $1.57M and bringing the position to 177,987 shares worth $50.7M. The position accounts for 0.04% of the portfolio, ranked #374.

Marshall Wace first reported a position in ONC in Q3 2016 and has held it in 17 quarters since. The position peaked at $130M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Marshall Wace held 177,987 shares of BeOne Medicines Ltd worth $50.7M as of Q2 2026.
  • Marshall Wace bought 5,344 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.57M.
  • BeOne Medicines Ltd made up 0.04% of Marshall Wace's portfolio in Q2 2026, its #374 holding.
  • Marshall Wace first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 17 quarters since.
  • Marshall Wace's BeOne Medicines Ltd position peaked at $130M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.